Hot off the Press: Subcutaneous Insulin for Mild to Moderate Diabetic Ketoacidosis.

Academic Emergency MedicineVolume 31, Issue 2 p. 187-189 HOT OFF THE PRESS Hot off the press: Subcutaneous insulin for mild to moderate diabetic ketoacidosis Suchismita Datta MD, Corresponding Author Suchismita Datta MD [email protected] orcid.org/0000-0003-2202-775X NYU Grossman Long Island School of Medicine, New York, New York, USA Correspondence Suchismita Datta, NYU Grossman Long Island School of Medicine, New York, NY 10016, USA. Email: [email protected]Search for more papers by this authorChristopher Bond MD, Christopher Bond MD orcid.org/0000-0002-1593-6659 Department of Emergency Medicine, University of Calgary, Calgary, Alberta, CanadaSearch for more papers by this authorWilliam Ken Milne MD, William Ken Milne MD Schulich School of Medicine and Dentistry, Western University, London, Ontario, CanadaSearch for more papers by this author Suchismita Datta MD, Corresponding Author Suchismita Datta MD [email protected] orcid.org/0000-0003-2202-775X NYU Grossman Long Island School of Medicine, New York, New York, USA Correspondence Suchismita Datta, NYU Grossman Long Island School of Medicine, New York, NY 10016, USA. Email: [email protected]Search for more papers by this authorChristopher Bond MD, Christopher Bond MD orcid.org/0000-0002-1593-6659 Department of Emergency Medicine, University of Calgary, Calgary, Alberta, CanadaSearch for more papers by this authorWilliam Ken Milne MD, William Ken Milne MD Schulich School of Medicine and Dentistry, Western University, London, Ontario, CanadaSearch for more papers by this author First published: 22 December 2023 https://doi.org/10.1111/acem.14853 Discussing: Griffey RT, Schneider RM, Girardi M, et al. The SQuID protocol (subcutaneous insulin in diabetic ketoacidosis): impacts on the ED operational metrics. Acad Emerg Med. 2023;30(8):800–808. Associated podcast: https://thesgem.com/2023/09/sgem414-the-squid-protocol/ Supervising Editor: Dr. Jeffrey Kline Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. CONFLICT OF INTEREST STATEMENT The authors declare no conflicts of interest. REFERENCES 1 Prevention CFDCA. National Diabetes Statistics Report: Coexisting Conditions and Complications. Centers for Disease Control and Prevention; 2021. Accessed February 21, 2023. https://www.cdc.gov/diabetes/data/statistics-report/coexisting-conditions-complications.html Google Scholar 2Desai D, Mehta D, Mathias P, Menon G, Schubart UK. Health care utilization and burden of diabetic ketoacidosis in the U.S. over the past decade: a nationwide analysis. Diabetes Care. 2018; 41(8): 1631-1638. 10.2337/dc17-1379 PubMedWeb of Science®Google Scholar 3Andrade-Castellanos CA, Colunga-Lozano LE, Delgado-Figueroa N, Gonzalez-Padilla DA. Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis. Cochrane Database Syst Rev. 2016; 1:CD011281. Google Scholar Volume31, Issue2February 2024Pages 187-189 ReferencesRelatedInformation